These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33571197)

  • 1. Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis.
    Chen X; Feng L; Yao H; Yang L; Qin Y
    PLoS One; 2021; 16(2):e0246463. PubMed ID: 33571197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of diazoxide in Japanese patients with hyperinsulinemic hypoglycemia.
    Komatsu Y; Nakamura A; Takihata M; Inoue Y; Yahagi S; Tajima K; Tsuchiya H; Takano T; Yamakawa T; Yoshida M; Miyoshi H; Terauchi Y
    Endocr J; 2016; 63(3):311-4. PubMed ID: 26598136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term diazoxide treatment in persistent hyperinsulinemic hypoglycemia of infancy: a patient report.
    Darendeliler F; Bundak R; Bas F; Saka N; Günöz H
    J Pediatr Endocrinol Metab; 1997; 10(1):79-81. PubMed ID: 9364348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necrotizing Enterocolitis in Neonates With Hyperinsulinemic Hypoglycemia Treated With Diazoxide.
    Keyes ML; Healy H; Sparger KA; Orth LE; Geha M; Roumiantsev S; Matute JD
    Pediatrics; 2021 Feb; 147(2):. PubMed ID: 33483452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diazoxide in the therapy of leucin sensitive hypoglycemia].
    Lücking T
    Monatsschr Kinderheilkd (1902); 1971 Jul; 119(7):428-9. PubMed ID: 5093940
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide.
    Herrera A; Vajravelu ME; Givler S; Mitteer L; Avitabile CM; Lord K; De León DD
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4365-4372. PubMed ID: 30247666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent neonatal hyperinsulinemic hypoglycemia in two siblings successfully treated with diazoxide.
    Wüthrich C; Schubiger G; Zuppinger K
    Helv Paediatr Acta; 1986 Dec; 41(5):455-9. PubMed ID: 3818333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment effect of diazoxide on 44 patients with congenital hyperinsulinism.
    Hu S; Xu Z; Yan J; Liu M; Sun B; Li W; Sang Y
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1119-22. PubMed ID: 23329758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of severe diazoxide toxicity.
    Silvani P; Camporesi A; Mandelli A; Wolfler A; Salvo I
    Paediatr Anaesth; 2004 Jul; 14(7):607-9. PubMed ID: 15200661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism.
    Brar PC; Heksch R; Cossen K; De Leon DD; Kamboj MK; Marks SD; Marshall BA; Miller R; Page L; Stanley T; Mitchell D; Thornton P
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32810255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher C-peptide levels and glucose requirements may identify neonates with transient hyperinsulinism hypoglycemia who will benefit from diazoxide treatment.
    Davidov AS; Elkon-Tamir E; Haham A; Shefer G; Weintrob N; Oren A; Lebenthal Y; Mandel D; Eyal O
    Eur J Pediatr; 2020 Apr; 179(4):597-602. PubMed ID: 31863303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy after prolonged diazoxide therapy for hyperinsulinemic hypoglycemia.
    Parker JJ; Allen DB
    J Pediatr; 1991 Jun; 118(6):906-9. PubMed ID: 2040926
    [No Abstract]   [Full Text] [Related]  

  • 13. Diazoxide for hyperinsulinism.
    Drug Ther Bull; 1970 Mar; 8(6):23-4. PubMed ID: 5440617
    [No Abstract]   [Full Text] [Related]  

  • 14. Epileptic phenotype in late-onset hyperinsulinemic hypoglycemia successfully treated by diazoxide.
    Descamps J; Ruello C; Perge K; de Bellescize J; Saint-Martin C; Nicolino M
    J Pediatr Endocrinol Metab; 2021 May; 34(5):667-673. PubMed ID: 33662190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of pulmonary hypertension in an infant treated with diazoxide.
    Nebesio TD; Hoover WC; Caldwell RL; Nitu ME; Eugster EA
    J Pediatr Endocrinol Metab; 2007 Aug; 20(8):939-44. PubMed ID: 17937066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide.
    Demirel F; Unal S; Çetin II; Esen I; Arasli A
    J Pediatr Endocrinol Metab; 2011; 24(7-8):603-5. PubMed ID: 21932611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrichosis due to diazoxide.
    Burton JL; Schutt WH; Caldwell IW
    Br J Dermatol; 1975 Dec; 93(6):707-11. PubMed ID: 1220817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver injury may increase the risk of diazoxide toxicity: a case report.
    Tas E; Mahmood B; Garibaldi L; Sperling M
    Eur J Pediatr; 2015 Mar; 174(3):403-6. PubMed ID: 25618267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diazoxide toxicity in a child with persistent hyperinsulinemic hypoglycemia of infancy: mixed hyperglycemic hyperosmolar coma and ketoacidosis.
    Mangla P; Hussain K; Ellard S; Flanagan SE; Bhatia V
    J Pediatr Endocrinol Metab; 2018 Aug; 31(8):943-945. PubMed ID: 29958183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Insufficiency Caused by Diazoxide in a Premature Neonate with Congenital Hyperinsulinism.
    Okada S; Fukunaga S; Ohta H; Furuta T; Hirano R; Motonaga T; Ishikawa Y
    Neuropediatrics; 2020 Jun; 51(3):211-214. PubMed ID: 31777044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.